GT Biopharma

$4.16 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About GT Biopharma

GT Biopharma, Inc. operates as a biotechnology company. The Company discovers, develops, and commercializes drugs of therapeutic molecules for the treatment of cancer, myeloma, osteolytic lesions, and other unmet medical needs. GT Biopharma serves customers worldwide.

Stock Analysis

last close $4.43
1-mo return -31%
3-mo return -43.3%
avg daily vol. 336.81T
52-week high 19.73
52-week low 2.58
market cap. $135M
forward pe -
annual div. -
roe -4556%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 27.6%
baraka

Subscribe now for daily local and international financial news

Subscribe